COVID-19 New Drug Concerns, Research Breakthroughs And Updated Mortality Statistics
A brief look at glucocorticoids, the Lancets updated mortality statistics, Hydroxychloroquine risks, lung treatments, viral treatment, and stem cell treatments
The Lancet Infectious Diseases: Comprehensive COVID-19 hospitalisation and death rate estimates help countries best prepare as global pandemic unfolds
https://www.eurekalert.org/pub_releases/2020-03/tl-pss_1033020.php#.XoKIMrdEpR0.wordpress
Mayo Clinic outlines approach for patients at risk of drug-induced sudden cardiac death in COVID-19
https://ekaprdweb01.eurekalert.org/pub_releases/2020-03/mc-mco032520.php
Individuals taking class of steroid medications at high risk for COVID-19
https://www.eurekalert.org/pub_releases/2020-03/tes-itc033120.php
Perhaps we will not need all the ventilators after all
https://www.eurekalert.org/pub_releases/2020-03/au-pww032620.php
HSC professor on team using stem cells to combat COVID-19 pneumonia
https://www.eurekalert.org/pub_releases/2020-03/uont-hpo032920.php
Nafamostat is expected to prevent the transmission of new coronavirus infection (COVID-19)
https://www.eurekalert.org/pub_releases/2020-03/tiom-nie032420.php
Researchers investigate potential treatments for COVID-19
https://ekaprdweb01.eurekalert.org/pub_releases/2020-03/asfm-rip032620.php
COVID-19: Stopgap measure to treat respiratory distress
https://www.eurekalert.org/pub_releases/2020-03/miot-asm032520.php
